Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Endosense raises $36 million for TactiCath launch: European roll-out of Endosense's TactiCath force-sensing cardiac arrhythmia ablation catheter will be funded by a $36 million "Series B" private placement, announced Sept. 1. Proceeds also will be used for a U.S. clinical trial to support a PMA submission, according to the company. Headquartered in Geneva, Endosense received European CE mark approval in May for TactiCath treatment of supraventricular tachycardia of the right atrium. TactiCath "is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure," and it "has the potential to improve the effectiveness, safety and reproducibility" of treatment, according to Endosense. Founded in 2003, the firm estimates that the competitive, worldwide catheter ablation market is worth over $500 million annually. The financing round was led by Edmond de Rothschild Investment Partners
You may also be interested in...
St. Jude Gains Force-Sensing Catheter Technology With Endosense Acquisition
The $170 million acquisition, plus milestones, gives St. Jude Medical access to contact-force-sensing catheter ablation technology, strengthening its cardiac ablation pipeline and offering opportunities to enhance currently marketed products.
Neuronetics Overcomes Negative Panel Review To Earn Clearance For NeuroStar
FDA cleared Neuronetics' NeuroStar transcranial magnetic stimulation system for drug-resistant depression, despite a negative advisory panel review, based on a pivotal study subset analysis
Big Pharma CEOs Suggest Policy Changes As They Return To Beijing
Global CEOs of J&J, Pfizer, AbbVie and Takeda were among the top pharma executives attending the China Development Forum in its first in-person meeting in three years, and highlighted a number of pharma-related policy changes they would like to see in China. Meanwhile, a Japanese employee of Astellas has been detained in the country for alleged espionage.